BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stolwijk C, Boonen A, van Tubergen A, Reveille JD. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am 2012;38:441-76. [PMID: 23083748 DOI: 10.1016/j.rdc.2012.09.003] [Cited by in Crossref: 122] [Cited by in F6Publishing: 95] [Article Influence: 13.6] [Reference Citation Analysis]
Number Citing Articles
1 Lahiri M, Teng GG, Cheung PP, Suresh E, Chia FL, Lui NL, Koh DR, Koh WH, Leong KP, Lim AYN, Ng SC, Thumboo J, Lau TC, Leong KH. Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti-rheumatic agents for the treatment of psoriatic arthritis. Int J Rheum Dis 2017;20:1527-40. [PMID: 26353916 DOI: 10.1111/1756-185X.12685] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Zabotti A, Luchetti MM, Selmi CF, Ramonda R, Grembiale RD, Dagna L, D'Angelo S, Cafaro G, De Vita S, Felicetti M, Marelli S, Frigerio D, Favalli EG. An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study. Front Med (Lausanne) 2021;8:711875. [PMID: 34631733 DOI: 10.3389/fmed.2021.711875] [Reference Citation Analysis]
3 Pedersen SJ, Maksymowych WP. Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology. Drugs 2018;78:1397-418. [PMID: 30171593 DOI: 10.1007/s40265-018-0971-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
4 Castro Rocha FA, Duarte-Monteiro AM, Henrique da Mota LM, Matias Dinelly Pinto AC, Fonseca JE. Microbes, helminths, and rheumatic diseases. Best Pract Res Clin Rheumatol 2020;34:101528. [PMID: 32448639 DOI: 10.1016/j.berh.2020.101528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Sharip A, Kunz J. Understanding the Pathogenesis of Spondyloarthritis. Biomolecules 2020;10:E1461. [PMID: 33092023 DOI: 10.3390/biom10101461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jang HS, Proos A, Koe L, Anderson J, Fulton R, Fernando SL. High accuracy of HLA-B*27 genotyping by allele-specific real-time polymerase chain reaction in a heterogeneous population compared to flow cytometry and single nucleotide polymorphism detection assays. Pathology 2020;52:256-61. [PMID: 31902620 DOI: 10.1016/j.pathol.2019.09.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Lim CSE, Sengupta R, Gaffney K. The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis. Rheumatology (Oxford) 2018;57:959-68. [PMID: 29029331 DOI: 10.1093/rheumatology/kex345] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Dashti N, Mahmoudi M, Aslani S, Jamshidi A. HLA-B*27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene 2018;670:15-21. [PMID: 29803000 DOI: 10.1016/j.gene.2018.05.092] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
9 Machado MA, Moura CS, Ferré F, Bernatsky S, Rahme E, Acurcio Fde A. Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis. Rev Saude Publica 2016;50:50. [PMID: 27556964 DOI: 10.1590/S1518-8787.2016050006265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
10 Torre-Alonso JC, Queiro R, Comellas M, Lizán L, Blanch C. Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature. Patient Prefer Adherence 2018;12:733-47. [PMID: 29780239 DOI: 10.2147/PPA.S162420] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
11 Kishimoto M, Taniguchi A, Fujishige A, Kaneko S, Haemmerle S, Porter BO, Kobayashi S. Efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis: 24-week results from an open-label phase 3 study (MEASURE 2-J). Modern Rheumatology 2020;30:132-40. [DOI: 10.1080/14397595.2018.1538004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Deodhar A, Yu D. Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis. Semin Arthritis Rheum 2017;47:343-50. [PMID: 28551170 DOI: 10.1016/j.semarthrit.2017.04.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
13 Kechida M. Update on Autoimmune Diseases Pathogenesis. Curr Pharm Des 2019;25:2947-52. [PMID: 31686634 DOI: 10.2174/1381612825666190709205421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Younger DS. I-Cubed (Infection, Immunity, and Inflammation) and the Human Microbiome. Neurol Clin 2016;34:863-74. [PMID: 27719998 DOI: 10.1016/j.ncl.2016.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Boel A, van Lunteren M, López-Medina C, Sieper J, van der Heijde D, van Gaalen FA. Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study. RMD Open 2022;8:e002174. [PMID: 35301267 DOI: 10.1136/rmdopen-2021-002174] [Reference Citation Analysis]
16 Kameda H, Kishimoto M, Kobayashi S, Tomita T, Morita A, Yamamura M. Axial Spondyloarthritis in Japan. Curr Rheumatol Rep 2022. [PMID: 35380380 DOI: 10.1007/s11926-022-01068-4] [Reference Citation Analysis]
17 Kroon FP, van der Burg LR, Ramiro S, Landewé RB, Buchbinder R, Falzon L, van der Heijde D. Nonsteroidal Antiinflammatory Drugs for Axial Spondyloarthritis: A Cochrane Review. J Rheumatol 2016;43:607-17. [PMID: 26834216 DOI: 10.3899/jrheum.150721] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
18 Lu CC, Huang GS, Lee TS, Chao E, Chen HC, Guo YS, Chu SJ, Liu FC, Kao SY, Hou TY, Chen CH, Chang DM, Lyu SY. MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis. J Transl Med 2021;19:298. [PMID: 34243762 DOI: 10.1186/s12967-021-02959-3] [Reference Citation Analysis]
19 Mahdinejad-Yazdi M, Sobhan MR, Dastgheib SA, Bahrami R, Shaker SH, Mirjalili H, Sadeghizadeh-Yazdi J, Zare-Shehneh M, Neamatzadeh H. A meta-analysis for association of TNF-α -308G>A polymorphism with susceptibility to Ankylosing Spondylitis. J Orthop 2021;26:79-87. [PMID: 34349398 DOI: 10.1016/j.jor.2021.07.015] [Reference Citation Analysis]
20 Coates LC, Gottlieb AB, Merola JF, Boone C, Szumski A, Chhabra A. Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value. J Rheumatol 2019;46:160-5. [DOI: 10.3899/jrheum.180249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
21 Oh BL, Lee JS, Lee EY, Lee HY, Yu HG. Recurrent anterior uveitis and subsequent incidence of ankylosing spondylitis: a nationwide cohort study from 2002 to 2013. Arthritis Res Ther 2018;20:22. [PMID: 29415753 DOI: 10.1186/s13075-018-1522-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Patil A, Upadhyaya S, Dawar R, Dadhaniya N, Sood I, Gupta SJ, Handa R. Anti‐drug antibodies and low serum trough infliximab levels correlate with disease activity measures in spondyloarthritis patients on an as‐needed infliximab treatment. Int J Rheum Dis 2019;22:1638-43. [DOI: 10.1111/1756-185x.13636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Karreman MC, Weel AEAM, van der Ven M, Vis M, Tchetverikov I, Nijsten TEC, Wakkee M, Hazes JMW, Luime JJ. Prevalence of Psoriatic Arthritis in Primary Care Patients With Psoriasis: PREVALENCE OF PsA IN PSORIASIS IN PRIMARY CARE. Arthritis & Rheumatology 2016;68:924-31. [DOI: 10.1002/art.39530] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
24 Burgos-Varga R, Wei JC, Rahman MU, Akkoc N, Haq SA, Hammoudeh M, Mahgoub E, Singh E, Llamado LJ, Shirazy K, Kotak S, Hammond C, Pedersen R, Shen Q, Vlahos B. The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study. Arthritis Res Ther 2016;18:132. [PMID: 27267875 DOI: 10.1186/s13075-016-1027-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
25 Rabelo CF, Baptista TSA, Petersen LE, Bauer ME, Keiserman MW, Staub HL. Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis. Open Access Rheumatol 2018;10:21-5. [PMID: 29750059 DOI: 10.2147/OARRR.S130176] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Sunkureddi P, Gibson D, Doogan S, Heid J, Benosman S, Park Y. Using Self-Reported Patient Experiences to Understand Patient Burden: Learnings from Digital Patient Communities in Ankylosing Spondylitis. Adv Ther 2018;35:424-37. [PMID: 29450863 DOI: 10.1007/s12325-018-0669-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Evans J, Sapsford M, McDonald S, Poole K, Raine T, Jadon DR. Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review. Ther Adv Musculoskelet Dis 2021;13:1759720X21996973. [PMID: 33786068 DOI: 10.1177/1759720X21996973] [Reference Citation Analysis]
28 Reinhardt A, Prinz I. Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis. Front Immunol 2018;9:885. [PMID: 29922283 DOI: 10.3389/fimmu.2018.00885] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
29 Wei JC, Liu CH, Tseng JC, Hsieh LF, Chen CH, Chen HH, Chen HA, Chen YC, Chou CT, Liao HT, Lin YC, Luo SF, Yang DH, Yeo KJ, Tsai WC; Taiwan Rheumatology Association (TRA). Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis. Int J Rheum Dis 2020;23:7-23. [PMID: 31777200 DOI: 10.1111/1756-185X.13752] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
30 Polachek A, Cook R, Chandran V, Abji F, Gladman D, Eder L. The Association Between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis. Arthritis Rheumatol 2018;70:756-62. [DOI: 10.1002/art.40423] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
31 Quin K, Madhoun HM. Ultrasound as a Biomarker in Rheumatic Diseases. Diagnostics (Basel) 2020;10:E933. [PMID: 33182835 DOI: 10.3390/diagnostics10110933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Lee YX, Kwan YH, Png WY, Lim KK, Tan CS, Lui NL, Chew EH, Thumboo J, Østbye T, Fong W. Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population. Clin Rheumatol 2017;36:2365-70. [PMID: 28378098 DOI: 10.1007/s10067-017-3585-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
33 Alejielat R, Khaleel A, Tarkhan AH. Differential gene expression analysis of ankylosing spondylitis shows deregulation of the HLA-DRB, HLA-DQB, ITM2A, and CTLA4 genes. Egypt J Med Hum Genet 2021;22. [DOI: 10.1186/s43042-021-00161-0] [Reference Citation Analysis]
34 Hwang MC, Lee MJ, Gensler LS, Ward MM, Brown MA, Eisen S, Learch TJ, Tahanan A, Rahbar MH, Ishimori ML, Weisman MH, Reveille JD. Longitudinal associations between depressive symptoms and clinical factors in ankylosing spondylitis patients: analysis from an observational cohort. Rheumatol Int 2020;40:1053-61. [PMID: 32166439 DOI: 10.1007/s00296-020-04544-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 van Tubergen A. The changing clinical picture and epidemiology of spondyloarthritis. Nat Rev Rheumatol 2015;11:110-8. [DOI: 10.1038/nrrheum.2014.181] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
36 Solmaz D, Bakirci S, Jibri Z, Sampaio M, Karsh J, Aydin SZ. Psoriasis is an independent risk factor for entheseal damage in axial spondyloarthritis. Seminars in Arthritis and Rheumatism 2020;50:42-7. [DOI: 10.1016/j.semarthrit.2019.06.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
37 van Wissen MAT, Teuwen MMH, van den Ende CHM, Vliet Vlieland TPM, den Broeder AA, van den Hout WB, Peter WF, van Schaardenburg D, van Tubergen AM, Gademan MGJ, van Weely SFE. Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials. Physiother Res Int 2021;:e1933. [PMID: 34780107 DOI: 10.1002/pri.1933] [Reference Citation Analysis]
38 Akasbi N, Nihad S, Sofia Z, Khadija EK, Taoufik H. Comparison of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondyltis from a Single Rheumatology Hospital in Morocco. Curr Rheumatol Rev 2020;16:240-4. [PMID: 30806321 DOI: 10.2174/1573397115666190222195923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
39 Arpa M, Şen B, Beyazal MS, Erel Ö. Evaluation of Thiol-disulfide Homeostasis in Active Ankylosing Spondylitis Patients. Reumatol Clin (Engl Ed) 2021:S1699-258X(21)00118-2. [PMID: 34016551 DOI: 10.1016/j.reuma.2021.03.007] [Reference Citation Analysis]
40 Tuncer T, Gilgil E, Kaçar C, Kurtaiş Y, Kutlay Ş, Bütün B, Yalçin P, Akarirmak Ü, Altan L, Ardiç F, Ardiçoğlu Ö, Altay Z, Cantürk F, Cerrahoğlu L, Çevik R, Demir H, Durmaz B, Dursun N, Duruöz T, Erdoğan C, Evcik D, Gürsoy S, Hizmetli S, Kaptanoğlu E, Kayhan Ö, Kirnap M, Kokino S, Kozanoğlu E, Kuran B, Nas K, Öncel S, Sindel D, Orkun S, Sarpel T, Savaş S, Şendur ÖF, Şenel K, Uğurlu H, Uzunca K, Tekeoğlu İ, Guillemin F. Prevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study. Arch Rheumatol 2018;33:128-36. [PMID: 30207568 DOI: 10.5606/ArchRheumatol.2018.6480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Lubrano E, Spadaro A, Amato G, Benucci M, Cavazzana I, Chimenti MS, Ciancio G, D׳alessandro G, Angelis RD, Lupoli S, Lurati AM, Naclerio C, Russo R, Semeraro A, Tomietto P, Zuccaro C, De Marco G. Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: A systematic review. Seminars in Arthritis and Rheumatism 2015;44:542-50. [DOI: 10.1016/j.semarthrit.2014.09.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
42 Braun J, Blanco R, Marzo-Ortega H, Gensler LS, van den Bosch F, Hall S, Kameda H, Poddubnyy D, van de Sande M, Wiksten AS, Porter BO, Shete A, Richards HB, Haemmerle S, Deodhar A. Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT. Arthritis Res Ther 2021;23:231. [PMID: 34481517 DOI: 10.1186/s13075-021-02613-9] [Reference Citation Analysis]
43 Hočevar A, Potočnik Pucelj N, Ješe R, Pavič-Nikolič M, Tomšič M, Rotar Z. The incidence of spondyloarthritis in Slovenia. Medicine (Baltimore) 2019;98:e16177. [PMID: 31261552 DOI: 10.1097/MD.0000000000016177] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Erbil J, Espinoza LR. Nonradiographic axial spondyloarthritis background and confounding factors of this new terminology: an appraisal. Clin Rheumatol 2015;34:407-11. [PMID: 25270567 DOI: 10.1007/s10067-014-2787-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
45 Kroon FP, van der Burg LR, Ramiro S, Landewé RB, Buchbinder R, van der Heijde D, Kroon FP. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd010952] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Landi M, Maldonado-Ficco H, Perez-Alamino R, Maldonado-Cocco JA, Citera G, Arturi P, Sampaio-Barros PD, Flores Alvarado DE, Burgos-Vargas R, Santos E, Palleiro D, Gutiérrez MA, Vieyra-Sousa E, Pimentel-Santos F, Paira SO, Berman A, Barrezueta CV, Vazquez-Mellado J, Collantes-Estevez E; RESPONDIA Group. Fundación Reumatológica Argentina “Dr. Osvaldo García Morteo. Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort. Medicine (Baltimore) 2016;95:e5652. [PMID: 28002334 DOI: 10.1097/MD.0000000000005652] [Cited by in Crossref: 42] [Cited by in F6Publishing: 18] [Article Influence: 8.4] [Reference Citation Analysis]
47 Raychaudhuri SP, Raychaudhuri SK. Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Res Ther 2017;19:51. [PMID: 28270233 DOI: 10.1186/s13075-017-1249-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
48 Boonen A, Sieper J, van der Heijde D, Dougados M, Bukowski JF, Valluri S, Vlahos B, Kotak S. The burden of non-radiographic axial spondyloarthritis. Semin Arthritis Rheum 2015;44:556-62. [PMID: 25532945 DOI: 10.1016/j.semarthrit.2014.10.009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
49 Haley EK, Matmusaev M, Hossain IN, Davin S, Martin TM, Ermann J. The impact of genetic background and sex on the phenotype of IL-23 induced murine spondyloarthritis. PLoS One 2021;16:e0247149. [PMID: 33983951 DOI: 10.1371/journal.pone.0247149] [Reference Citation Analysis]
50 Kerola AM, Rollefstad S, Kazemi A, Wibetoe G, Sexton J, Mars N, Kauppi M, Kvien TK, Haavardsholm EA, Semb AG. Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents. Scand J Rheumatol 2022;:1-9. [PMID: 35014920 DOI: 10.1080/03009742.2021.1997436] [Reference Citation Analysis]
51 Tomita T, Sato M, Esterberg E, Parikh RC, Hagimori K, Nakajo K. Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: A hospital claims database analysis. Mod Rheumatol 2021;31:431-41. [PMID: 32476522 DOI: 10.1080/14397595.2020.1775927] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Baraliakos X, Braun J. Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences? RMD Open 2015;1:e000053. [PMID: 26557375 DOI: 10.1136/rmdopen-2015-000053] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
53 Akkoc N, Khan MA. Is Axial Spondyloarthritis More Common Than Rheumatoid Arthritis? Curr Rheumatol Rep 2020;22:54. [PMID: 32712723 DOI: 10.1007/s11926-020-00934-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 McKay KM, Lim LL, Van Gelder RN. Rational laboratory testing in uveitis: A Bayesian analysis. Surv Ophthalmol 2021;66:802-25. [PMID: 33577878 DOI: 10.1016/j.survophthal.2021.02.002] [Reference Citation Analysis]
55 Pedersen SJ, Maksymowych WP. The Pathogenesis of Ankylosing Spondylitis: an Update. Curr Rheumatol Rep 2019;21:58. [PMID: 31712904 DOI: 10.1007/s11926-019-0856-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
56 Gilio M, Scarano E, Padula A, Tramontano G, DʼAngelo S, Olivieri I. Diffuse Idiopathic Skeletal Hyperostosis in an HLA-B27-Positive Subject. J Clin Rheumatol 2019;25:e94-8. [PMID: 30048388 DOI: 10.1097/RHU.0000000000000865] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Hammoudeh M, Al Rayes H, Alawadhi A, Gado K, Shirazy K, Deodhar A. Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation. Int J Rheumatol 2015;2015:178750. [PMID: 26793241 DOI: 10.1155/2015/178750] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Breban M, Beaufrère M, Glatigny S. The microbiome in spondyloarthritis. Best Pract Res Clin Rheumatol 2019;33:101495. [PMID: 32173258 DOI: 10.1016/j.berh.2020.101495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
59 Kömel Pimenta PR, Ribeiro da Silva MR, Ribeiro Dos Santos JB, Kakehasi AM, Assis Acurcio F, Alvares-Teodoro J. Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study. J Comp Eff Res 2021;10:509-17. [PMID: 33728937 DOI: 10.2217/cer-2020-0275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Subramaniam K, Tymms K, Shadbolt B, Pavli P. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors: Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors. Intern Med J 2015;45:1154-60. [DOI: 10.1111/imj.12891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
61 Costantino F, Talpin A, Said-nahal R, Goldberg M, Henny J, Chiocchia G, Garchon H, Zins M, Breban M. Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann Rheum Dis 2015;74:689-93. [DOI: 10.1136/annrheumdis-2013-204436] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 6.8] [Reference Citation Analysis]
62 Steel KJA, Srenathan U, Ridley M, Durham LE, Wu SY, Ryan SE, Hughes CD, Chan E, Kirkham BW, Taams LS. Polyfunctional, Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+ T Cells in Psoriatic Arthritis. Arthritis Rheumatol 2020;72:435-47. [PMID: 31677365 DOI: 10.1002/art.41156] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
63 Taitt HA, Balakrishnan R. Spondyloarthritides. Emerg Med Clin North Am 2022;40:159-78. [PMID: 34782086 DOI: 10.1016/j.emc.2021.08.005] [Reference Citation Analysis]
64 Kroon FP, van der Burg LR, Ramiro S, Landewé RB, Buchbinder R, Falzon L, van der Heijde D. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev 2015;:CD010952. [PMID: 26186173 DOI: 10.1002/14651858.CD010952.pub2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]
65 Lai TL, Yim CW, Leung MC, Wong PY, Ng WL. Clinical characteristics and comorbidities of psoriatic arthritis (PsA) in Hong Kong. Hong Kong Bulletin on Rheumatic Diseases 2018;18:47-55. [DOI: 10.2478/hkbrd-2018-0005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis: Analysis of SpA Prevalence. Arthritis Care & Research 2016;68:1320-31. [DOI: 10.1002/acr.22831] [Cited by in Crossref: 131] [Cited by in F6Publishing: 108] [Article Influence: 21.8] [Reference Citation Analysis]
67 Torgutalp M, Poddubnyy D. IL-17 inhibition in axial spondyloarthritis: current and future perspectives. Expert Opin Biol Ther 2019;19:631-41. [PMID: 30957574 DOI: 10.1080/14712598.2019.1605352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
68 Sharon Y, Friling R, Luski M, Campoverde BQ, Amer R, Kramer M. Uveitic Glaucoma: Long-term Clinical Outcome and Risk Factors for Progression. Ocular Immunology and Inflammation 2016;25:740-7. [DOI: 10.1080/09273948.2016.1255341] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
69 Inderjeeth CA, Boland E, Connor C, Johnson C, Jacques A, McQuade J. Evaluation of an ankylosing spondylitis education and self-management program: Beneficial effects on ankylosing spondylitis specific outcomes. Int J Rheum Dis 2021;24:434-44. [PMID: 33694321 DOI: 10.1111/1756-185X.14070] [Reference Citation Analysis]
70 Willemsen M, Abdul-Hamid M, Schoonbrood THM. NLRC4 inflammasomopathy with spondyloarthritis and a complete response to TNF inhibition. J Allergy Clin Immunol Pract 2019;7:2443-2446.e2. [PMID: 30930271 DOI: 10.1016/j.jaip.2019.03.028] [Reference Citation Analysis]
71 Waldron T. Joint Disease. Ortner's Identification of Pathological Conditions in Human Skeletal Remains. Elsevier; 2019. pp. 719-48. [DOI: 10.1016/b978-0-12-809738-0.00020-x] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
72 Sayed MI, Hashad DI, Soliman EA, Talaaba MM. Association of IL-23R gene single nucleotide polymorphism; rs 11209026 with incidence and severity of ankylosing spondylitis in a cohort of Egyptian patients. Alexandria Journal of Medicine 2018;54:299-302. [DOI: 10.1016/j.ajme.2017.08.005] [Reference Citation Analysis]
73 Bodis G, Toth V, Schwarting A. Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases. Rheumatol Ther 2018;5:5-20. [PMID: 29516402 DOI: 10.1007/s40744-018-0100-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 12.8] [Reference Citation Analysis]
74 Agca R, Smulders Y, Nurmohamed M. Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice. Heart 2021:heartjnl-2019-316378. [PMID: 33674356 DOI: 10.1136/heartjnl-2019-316378] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Andreasen RA, Kristensen LE, Ellingsen T, Christensen R, Baraliakos X, Wied J, Aalykke C, Ulstrup T, Schiøttz-Christensen B, Horn HC, Emamifar A, Duerlund B, Fischer L, Hansen IMJ. Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study. BMJ Open 2017;7:e015536. [PMID: 28698330 DOI: 10.1136/bmjopen-2016-015536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
76 Donat R, Mokrane FZ, Rousseau H, Dedouit F, Telmon N, Crubézy É. The antiquity of the spondyloarthritides: Presentation of one of the oldest Neolithic cases in Western Europe. Int J Paleopathol 2019;24:229-35. [PMID: 30597411 DOI: 10.1016/j.ijpp.2018.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Tran-Duy A, Boonen A, van de Laar MA, Severens JL. Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study. Cost Eff Resour Alloc 2015;13:18. [PMID: 26451133 DOI: 10.1186/s12962-015-0044-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
78 Vasile M, Corinaldesi C, Antinozzi C, Crescioli C. Vitamin D in autoimmune rheumatic diseases: A view inside gender differences. Pharmacological Research 2017;117:228-41. [DOI: 10.1016/j.phrs.2016.12.038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
79 Braun J, Baraliakos X, Kiltz U, Heldmann F, Sieper J. Classification and Diagnosis of Axial Spondyloarthritis — What Is the Clinically Relevant Difference? J Rheumatol 2015;42:31-8. [DOI: 10.3899/jrheum.130959] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
80 López-Medina C, Moltó A. Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis. Best Pract Res Clin Rheumatol 2018;32:241-53. [PMID: 30527429 DOI: 10.1016/j.berh.2018.10.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
81 Baraliakos X, Richter A, Feldmann D, Ott A, Buelow R, Schmidt CO, Braun J. Which factors are associated with bone marrow oedema suspicious of axial spondyloarthritis as detected by MRI in the sacroiliac joints and the spine in the general population? Ann Rheum Dis 2021;80:469-74. [DOI: 10.1136/annrheumdis-2020-218669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
82 Agten CA, Zubler V, Zanetti M, Binkert CA, Kolokythas O, Prentl E, Buck FM, Pfirrmann CWA. Postpartum Bone Marrow Edema at the Sacroiliac Joints May Mimic Sacroiliitis of Axial Spondyloarthritis on MRI. AJR Am J Roentgenol 2018;211:1306-12. [PMID: 30247978 DOI: 10.2214/AJR.17.19404] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
83 Rahman MA, Thomas R. The SKG model of spondyloarthritis. Best Practice & Research Clinical Rheumatology 2017;31:895-909. [DOI: 10.1016/j.berh.2018.07.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
84 Mease PJ, Collier DH, Saunders KC, Li G, Kremer JM, Greenberg JD. Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registry. RMD Open 2015;1:e000181. [PMID: 26819748 DOI: 10.1136/rmdopen-2015-000181] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
85 Liang L, Pan Y, Wu D, Pang Y, Xie Y, Fang H. Effects of Multidisciplinary Team-Based Nurse-led Transitional Care on Clinical Outcomes and Quality of Life in Patients With Ankylosing Spondylitis. Asian Nursing Research 2019;13:107-14. [DOI: 10.1016/j.anr.2019.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
86 Chen Y, Chung H, Zhao C, Wong A, Zhen Z, Tsang HH, Lau C, Tse H, Yiu K. Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis. Rheumatology 2015;54:292-301. [DOI: 10.1093/rheumatology/keu337] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
87 Strand V, Rao SA, Shillington AC, Cifaldi MA, Mcguire M, Ruderman EM. Prevalence of Axial Spondyloarthritis in United States Rheumatology Practices: Assessment of SpondyloArthritis International Society Criteria Versus Rheumatology Expert Clinical Diagnosis: ASAS Criteria Versus Clinical Diagnosis in Axial SpA. Arthritis Care & Research 2013;65:1299-306. [DOI: 10.1002/acr.21994] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
88 Bodis G, Toth V, Schwarting A. Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases. In: Boegel S, editor. HLA Typing. New York: Springer; 2018. pp. 11-29. [DOI: 10.1007/978-1-4939-8546-3_2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
89 Genevay S, Courvoisier DS, Konstantinou K, Kovacs FM, Marty M, Rainville J, Norberg M, Kaux J, Cha TD, Katz JN, Atlas SJ. Clinical classification criteria for radicular pain caused by lumbar disc herniation: the radicular pain caused by disc herniation (RAPIDH) criteria. The Spine Journal 2017;17:1464-71. [DOI: 10.1016/j.spinee.2017.05.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
90 Cappelli LC, Thomas MA, Bingham CO 3rd, Shah AA, Darrah E. Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis. Immunol Rev 2020;294:106-23. [PMID: 31930524 DOI: 10.1111/imr.12832] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
91 Tuompo R, Lääveri T, Hannu T, Pakkanen SH, Kirveskari J, Leirisalo-Repo M, Kantele A. Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC). Ann Rheum Dis 2020;79:605-11. [PMID: 32179576 DOI: 10.1136/annrheumdis-2019-216736] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
92 Sieper J, Braun J, Dougados M, Baeten D. Axial spondyloarthritis. Nat Rev Dis Primers 2015;1:15013. [PMID: 27188328 DOI: 10.1038/nrdp.2015.13] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 9.3] [Reference Citation Analysis]
93 Karreman MC, Luime JJ, Hazes JMW, Weel AEAM. The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis. 2017;11:631-642. [PMID: 28453761 DOI: 10.1093/ecco-jcc/jjw199] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
94 Nygaard A, Ljungdalh PS, Iachina M, Nikolov TN, Schiøttz-Christensen B. Incidence of ankylosing spondylitis and spondyloarthritis in 2000-2013: a nationwide Danish cohort study. Scand J Rheumatol 2020;49:21-7. [PMID: 31354008 DOI: 10.1080/03009742.2019.1616324] [Reference Citation Analysis]
95 van Onna M, Gorter S, van Meerendonk A, van Tubergen A. General practitioners' perceptions of their ability to identify and refer patients with suspected axial spondyloarthritis: a qualitative study. J Rheumatol 2014;41:897-901. [PMID: 24692524 DOI: 10.3899/jrheum.131293] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
96 Braun J, Baraliakos X, Regel A, Kiltz U. Assessment of spinal pain. Best Pract Res Clin Rheumatol 2014;28:875-87. [PMID: 26096091 DOI: 10.1016/j.berh.2015.04.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
97 Jhaj G, Kopplin LJ. Ocular features of the HLA-B27-positive seronegative spondyloarthropathies. Current Opinion in Ophthalmology 2018;29:552-7. [DOI: 10.1097/icu.0000000000000525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
98 Molto A, Sieper J. Peripheral spondyloarthritis: Concept, diagnosis and treatment. Best Pract Res Clin Rheumatol 2018;32:357-68. [PMID: 31171308 DOI: 10.1016/j.berh.2019.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
99 Garcia Ferrer HR, Azan A, Iraheta I, Von Feldt J, Espinoza LR, Manasson J, Scher JU, Garcia Kutzbach A, Ogdie A. Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up. Clin Rheumatol 2018;37:415-22. [PMID: 29139030 DOI: 10.1007/s10067-017-3911-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
100 Peffers MJ, Smagul A, Anderson JR. Proteomic analysis of synovial fluid: current and potential uses to improve clinical outcomes. Expert Rev Proteomics 2019;16:287-302. [PMID: 30793992 DOI: 10.1080/14789450.2019.1578214] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
101 Abdelsalam A, Tharwat S, Almauty MA, Barakat AF, Enein AF, Abdelsalam N, Awad M, Shahin D. Demographic, clinical and radiological characteristics of seronegative spondyloarthritis Egyptian patients: A rheumatology clinic experience in Mansoura. The Egyptian Rheumatologist 2017;39:109-14. [DOI: 10.1016/j.ejr.2016.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 2.6] [Reference Citation Analysis]
102 Pons M, Dougados M, Costedoat-Chalumeau N, Briot K, Goupille P, Roux C, Molto A. Pregnancy rates and outcomes in early axial spondyloarthritis: An analysis of the DESIR cohort. Joint Bone Spine 2021;88:105075. [PMID: 32947013 DOI: 10.1016/j.jbspin.2020.09.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Rahmawati LD, Soeroso J, Aryati. The roles of Single Nucleotide Polymorphism (SNP) Endoplasmic Reticulum Aminopeptidase 1 (ERAP 1) gene in axial spondyloarthritis Indonesian adults. Annals of Medicine and Surgery 2022;77:103675. [DOI: 10.1016/j.amsu.2022.103675] [Reference Citation Analysis]
104 Samsel M, Kacki S, Villotte S. Palaeopathological diagnosis of spondyloarthropathies: Insights from the biomedical literature. International Journal of Paleopathology 2014;7:70-5. [DOI: 10.1016/j.ijpp.2014.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
105 Dolcino M, Lunardi C, Ottria A, Tinazzi E, Patuzzo G, Puccetti A. Crossreactive autoantibodies directed against cutaneous and joint antigens are present in psoriatic arthritis. PLoS One 2014;9:e115424. [PMID: 25514237 DOI: 10.1371/journal.pone.0115424] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
106 Braun J. Axial spondyloarthritis including ankylosing spondylitis. Rheumatology (Oxford) 2018;57:vi1-3. [PMID: 30445482 DOI: 10.1093/rheumatology/key079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
107 Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:65-73. [PMID: 23999006 DOI: 10.1136/annrheumdis-2013-203582] [Cited by in Crossref: 169] [Cited by in F6Publishing: 144] [Article Influence: 18.8] [Reference Citation Analysis]